Dr David Jamieson
Dr Jo Lee
Dr Nicola Cresti
Melanie Griffin
Julieann Sludden
et al. | Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil | 2014 |
|
Professor John Isaacs
Dr Jo Lee
| Effect of Tocilizumab on Hematologic Markers Implicates Interleukin-6 Signaling in the Anemia of Rheumatoid Arthritis | 2011 |
|
Dr Jo Lee
Dr Olivier Binda
| Hypoxia-induced methylation of a pontin chromatin remodeling factor | 2011 |
|
Dr Jo Lee
Dr Olivier Binda
| Negative regulation of hypoxic responses via induced Reptin methylation | 2010 |
|
Dr Jo Lee
Dr Mark Verrill
Julieann Sludden
Melanie Griffin
Sharon Erb
et al. | Pharmacogenetic influences on outcome from AC chemotherapy in the treatment of breast cancer | 2007 |
|
Dr Jo Lee
Julieann Sludden
Professor Alan Boddy
Dr Mark Verrill
| Investigation of multi-drug resistance 1 (MDR1) and cytochrome P4502C8 (CYP2C8) pharmacogenetics on outcome from treatment of advanced breast cancer using paclitaxel in a UK national trial of a weekly versus 3-weekly schedule. | 2006 |
|
